Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Sclerosis, Systemic

fluorodeoxyglucose f18 has been researched along with Sclerosis, Systemic in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's0 (0.00)29.6817
2010's5 (55.56)24.3611
2020's3 (33.33)2.80

Authors

AuthorsStudies
Bastos, AL; Correa, RA; Ferreira, CS; Ferreira, GA; Mamede, M; Mancuzo, EV; Santos, FPST; Teixeira, MM1
Hoekstra, OS; Meijboom, LJ; Nossent, EJ; Peelen, DM; Van der Laken, CJ; Voskuyl, AE; Zwezerijnen, BGJC1
Baillet, C; Béhal, H; Hachulla, E; Huglo, D; Launay, D; Le Gouellec, N; Ledoult, E; Mékinian, A; Morelle, M; Remy-Jardin, M; Sobanski, V; Soussan, M1
Mékinian, A; Sgard, B; Soussan, M1
Gatidis, S; Henes, JC; Horger, M; La Fougère, C; Nikolaou, K; Sauter, AW; Schwenzer, NF1
Low, AHL; Marchesseau, S; Ng, DC; Ng, SA; Totman, JJ; Wang, YT; Xie, W1
Allanore, Y; Avouac, J; Bellando-Randone, S; Blagojevic, J; Bruni, C; Cavigli, E; De Cristofaro, MT; Distler, O; Guiducci, S; Lepri, G; Matucci-Cerinic, M; Mihai, C; Moggi-Pignone, A; Passeri, A; Tartarelli, L; Tofani, L1
Brillet, PY; Cohen, C; Dhote, R; Eder, V; Fain, O; Fauchais, AL; Mekinian, A; Nunes, H; Pop, G; Soussan, M; Uzunhan, Y; Valeyre, D1
Amor, B; Crouzel, C; Duboc, D; Guérin, F; Kahan, A; Loc'h, C; Maziere, B; Menkès, CJ; Strauch, G; Syrota, A1

Trials

1 trial(s) available for fluorodeoxyglucose f18 and Sclerosis, Systemic

ArticleYear
Comprehensive metabolic and morphologic disease characterization in systemic sclerosis: initial results using combined positron emission tomography and magnetic resonance imaging.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2019, Volume: 63, Issue:2

    Topics: Adult; Biological Transport; Biomarkers; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Scleroderma, Systemic

2019

Other Studies

8 other study(ies) available for fluorodeoxyglucose f18 and Sclerosis, Systemic

ArticleYear
PET/CT and inflammatory mediators in systemic sclerosis-associated interstitial lung disease.
    Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia, 2022, Volume: 48, Issue:4

    Topics: Adult; Biomarkers; Cross-Sectional Studies; Fluorodeoxyglucose F18; Humans; Inflammation Mediators; Ligands; Lung; Lung Diseases, Interstitial; Positron Emission Tomography Computed Tomography; Scleroderma, Systemic

2022
The quantitative assessment of interstitial lung disease with positron emission tomography scanning in systemic sclerosis patients.
    Rheumatology (Oxford, England), 2020, 06-01, Volume: 59, Issue:6

    Topics: Adult; Aged; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases, Interstitial; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Scleroderma, Systemic; Sjogren's Syndrome

2020
    Arthritis research & therapy, 2021, 03-06, Volume: 23, Issue:1

    Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Lung; Lung Diseases, Interstitial; Middle Aged; Pilot Projects; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Scleroderma, Systemic

2021
Intense 18F-fluorodeoxyglucose Uptake in Systemic Sclerosis with Diffuse Calcinosis.
    The Journal of rheumatology, 2017, Volume: 44, Issue:5

    Topics: Aged; Calcinosis; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Scleroderma, Systemic

2017
    European journal of radiology, 2018, Volume: 105

    Topics: Computer Simulation; Cross-Over Studies; Female; Fibrosis; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Inflammation; Intestinal Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Scleroderma, Systemic

2018
18F-fluorodeoxyglucose positron-emission tomography/CT and lung involvement in systemic sclerosis.
    Annals of the rheumatic diseases, 2019, Volume: 78, Issue:4

    Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Lung Diseases, Interstitial; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Scleroderma, Systemic

2019
18F-fluorodeoxyglucose positron emission tomography/computer tomography as an objective tool for assessing disease activity in Sjögren's syndrome.
    Autoimmunity reviews, 2013, Volume: 12, Issue:11

    Topics: Aged; Amino Acyl-tRNA Synthetases; Arthritis, Rheumatoid; Autoantibodies; Female; Fluorodeoxyglucose F18; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Scleroderma, Systemic; Sjogren's Syndrome; Tomography, X-Ray Computed

2013
The effect of nifedipine on myocardial perfusion and metabolism in systemic sclerosis. A positron emission tomographic study.
    Arthritis and rheumatism, 1991, Volume: 34, Issue:2

    Topics: Animals; Coronary Circulation; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Myocardium; Nifedipine; Potassium Radioisotopes; Scleroderma, Systemic; Tomography, Emission-Computed

1991